Komori
Governance7096StemCell InstituteInformation and Communications, Services and Others

Matters Concerning Controlling Shareholders

NIHON TRIM CO.,LTD., the parent company, is identified as the parent company directly holding 71.3% of the voting rights in the Company. The disclosure also indicates that the Company's Representative Director and President concurrently serves as a non-executive director of NIHON TRIM CO.,LTD.

Worth reading
62In focus
Scored from 2 of 5 sections
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
71.3
Voting rights ownership ratio (%)
Wording
Definitive
How definitive the wording is.

Governance structure

Controlling shareholder
NIHON TRIM CO.,LTD.71.30%Voting rights

parent company; voting rights ownership ratio: 71.3%; directly owned: 71.3%; portion included in aggregate: —). Listed on the Tokyo Stock Exchange Prime Market.

When one company holds most of the voting rights, its wishes are more likely to prevail in management. How the interests of minority shareholders are protected is a key issue.

Changes this time

Shimizu Takafumi (清水崇文), the Company's Representative Director and President, was elected as a non-executive director of NIHON TRIM CO.,LTD. at the company's annual general meeting of shareholders held on 23 June 2026. No other changes from the previous disclosure are stated.

Governance structure
ItemDetails
Controlling shareholderNIHON TRIM CO.,LTD. (parent company; voting rights ownership ratio: 71.3%; directly owned: 71.3%; portion included in aggregate: —). Listed on the Tokyo Stock Exchange Prime Market.
Changes this timeShimizu Takafumi (清水崇文), the Company's Representative Director and President, was elected as a non-executive director of NIHON TRIM CO.,LTD. at the company's annual general meeting of shareholders held on 23 June 2026. No other changes from the previous disclosure are stated.
Items this document does not state (6)
Corporate Governance StructureNumber of directorsNumber of independent officersCommitteePolicy on cross-shareholdingsTakeover defenses

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The concurrent directorship at NIHON TRIM CO.,LTD. is intended to contribute to strengthening its decision-making and governance structure by leveraging expertise in the medical field and overseas business, as well as management experience at the Company, and by drawing on an understanding of the business operations and management strategies of the parent company's group as a whole. To protect minority shareholders, the Company states that it will conduct only transactions whose business rationale is clear and whose terms are appropriate, and will obtain proper approval in accordance with its Approval Regulations, Authority Regulations and other applicable rules.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Matters Concerning Controlling Shareholders | StemCell Institute (7096) timely disclosure | Komori